​

Glaukos (GKOS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GKOS Stock Forecast

Glaukos (GKOS) stock forecast, based on 24 Wall Street analysts, predicts a 12-month average price target of $141.78, with a high of $165.00 and a low of $122.00. This represents a 23.64% increase from the last price of $114.67.

$75 $93 $111 $129 $147 $165 High: $165 Avg: $141.78 Low: $122 Last Closed Price: $114.67

GKOS Stock Rating

Glaukos stock's rating consensus is Buy, based on 24 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 18 Buy (75.00%), 5 Hold (20.83%), 1 Sell (4.17%), and 0 Strong Sell (0.00%).

Buy
Total 24 0 1 5 18 Strong Sell Sell Hold Buy Strong Buy

GKOS Price Target Upside V Benchmarks

TypeNameUpside
StockGlaukos23.64%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks23.11%

Price Target Trends

1M3M12M
# Anlaysts41120
Avg Price Target$148.50$138.18$129.10
Last Closing Price$114.67$114.67$114.67
Upside/Downside29.50%20.50%12.58%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 26311-1-15
Jan, 26311-1-15
Dec, 2531111-16
Nov, 2531111-16
Oct, 2531021-16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 28, 2026BTIG$131.00$125.464.42%14.24%
Jan 22, 2026Stifel Nicolaus$160.00$124.1628.87%39.53%
Jan 14, 2026Piper Sandler$165.00$100.6263.98%43.89%
Jan 09, 2026Goldman Sachs$138.00$114.1520.89%20.35%
Jan 02, 2026Stephens$145.00$112.9128.42%26.45%
Dec 23, 2025UBS$145.00$117.0923.84%26.45%
Dec 18, 2025Truist Financial$145.00$115.8525.16%26.45%
Dec 17, 2025Piper Sandler$61.00$113.76-46.38%-46.80%
Dec 09, 2025Needham$125.00$108.8214.87%9.01%
Nov 10, 2025Danielle AntalffyUBS$140.00$86.2262.38%22.09%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 28, 2026BTIGBuyBuyhold
Jan 14, 2026Piper SandlerOverweightOverweighthold
Jan 09, 2026Goldman SachsBuyBuyhold
Jan 02, 2026StephensOverweightOverweighthold
Jan 02, 2026BTIGBuyBuyhold
Dec 23, 2025UBSBuyBuyhold
Dec 17, 2025Piper SandlerOverweightOverweighthold
Dec 11, 2025CitigroupBuyBuyhold
Dec 09, 2025NeedhamBuyBuyhold
Nov 10, 2025UBSBuyBuyhold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.07$-2.09$-2.78$-2.77----
Avg Forecast$-0.88$-2.20$-2.22$-1.82$-1.05$-0.25$0.42$1.18
High Forecast$-0.82$-2.02$-2.16$-1.71$-0.75$0.08$0.44$1.24
Low Forecast$-0.92$-2.30$-2.26$-2.00$-1.32$-0.38$0.39$1.12
Surprise %21.59%-5.00%25.23%52.20%----

Revenue Forecast

$250M $400M $550M $700M $850M $1B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$294.01M$282.86M$314.71M$383.48M----
Avg Forecast$288.16M$279.63M$313.00M$378.54M$479.13M$609.94M$745.10M$916.05M
High Forecast$299.38M$289.59M$313.16M$378.96M$499.83M$610.76M$776.53M$954.70M
Low Forecast$273.19M$261.89M$312.87M$377.81M$458.02M$609.12M$713.86M$877.64M
Surprise %2.03%1.16%0.55%1.31%----

Net Income Forecast

$-200M $-140M $-80M $-20M $40M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-49.59M$-99.19M$-134.66M$-146.37M----
Avg Forecast$-60.89M$-56.35M$-134.66M$-89.64M$-50.13M$-7.30M$20.10M$57.15M
High Forecast$-45.79M$-39.19M$-95.11M$-82.63M$-36.24M$4.00M$21.20M$60.29M
Low Forecast$-75.99M$-73.50M$-174.21M$-96.64M$-64.01M$-18.60M$19.00M$54.04M
Surprise %-18.55%76.04%-63.29%----

GKOS Forecast FAQ

Is Glaukos stock a buy?

Glaukos stock has a consensus rating of Buy, based on 24 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 18 Buy, 5 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Glaukos is a favorable investment for most analysts.

What is Glaukos's price target?

Glaukos's price target, set by 24 Wall Street analysts, averages $141.78 over the next 12 months. The price target range spans from $122 at the low end to $165 at the high end, suggesting a potential 23.64% change from the previous closing price of $114.67.

How does Glaukos stock forecast compare to its benchmarks?

Glaukos's stock forecast shows a 23.64% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (23.11%).

What is the breakdown of analyst ratings for Glaukos over the past three months?

  • February 2026: 20.00% Strong Buy, 73.33% Buy, 0% Hold, 6.67% Sell, 0% Strong Sell.
  • January 2026: 20.00% Strong Buy, 73.33% Buy, 0% Hold, 6.67% Sell, 0% Strong Sell.
  • December 2025: 18.75% Strong Buy, 68.75% Buy, 6.25% Hold, 6.25% Sell, 0% Strong Sell.

What is Glaukos’s EPS forecast?

Glaukos's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.05, marking a -62.09% decrease from the reported $-2.77 in 2024. Estimates for the following years are $-0.25 in 2026, $0.42 in 2027, and $1.18 in 2028.

What is Glaukos’s revenue forecast?

Glaukos's average annual revenue forecast for its fiscal year ending in December 2025 is $479.13M, reflecting a 24.94% increase from the reported $383.48M in 2024. The forecast for 2026 is $609.94M, followed by $745.1M for 2027, and $916.05M for 2028.

What is Glaukos’s net income forecast?

Glaukos's net income forecast for the fiscal year ending in December 2025 stands at $-50.125M, representing a -65.75% decrease from the reported $-146M in 2024. Projections indicate $-7.3M in 2026, $20.1M in 2027, and $57.15M in 2028.